COPENHAGEN, Nov 6 (Reuters) – Danish drugmaker Leo Pharma is considering postponing its planned initial public offering until 2027 due to the ongoing turmoil in global financial markets, daily Berlingske reported on Friday, citing unnamed sources.
A company spokesperson declined to comment when contacted by Reuters.
(Reporting by Stine Jacobsen and Vera Dvorakova, editing by Terje Solsvik)
Comments